Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ehrlich

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2 responding CD4 <sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Cardiovascular Toxicology|July 29, 2025
Per- and Polyfluoroalkyl Substances (PFAS) Enhance Cholesterol Accumulation and Dysregulate Inflammatory Responses in MacrophagesJack C Connolly, Yasuhiro Ishihara, Emma Sawaya, et al.
Frontiers in Immunology|November 30, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4<sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Bioconjugate Chemistry|April 21, 2001
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis CP Bailon, A Palleroni, C A Schaffer, et al.
Nature Communications|September 16, 2023
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Nature Communications|April 26, 2024
Author Correction: Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Immunity|February 14, 2016
The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated InflammationWook-Jin Chae, Allison K Ehrlich, Pamela Y Chan, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2 responding CD4 <sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Cardiovascular Toxicology|July 29, 2025
Per- and Polyfluoroalkyl Substances (PFAS) Enhance Cholesterol Accumulation and Dysregulate Inflammatory Responses in MacrophagesJack C Connolly, Yasuhiro Ishihara, Emma Sawaya, et al.
Frontiers in Immunology|November 30, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4<sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Bioconjugate Chemistry|April 21, 2001
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis CP Bailon, A Palleroni, C A Schaffer, et al.
Nature Communications|September 16, 2023
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Nature Communications|April 26, 2024
Author Correction: Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumoniaGiorgia Renga, Fiorella D'Onofrio, Marilena Pariano, et al.
Immunity|February 14, 2016
The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated InflammationWook-Jin Chae, Allison K Ehrlich, Pamela Y Chan, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Pageof 8